AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.

The Asus ProArt PZ13 is a compact tablet-laptop hybrid that houses a stunning 3K OLED screen and a ridiculously, long-lasting ...

Huawei has just announced two new flagship tablets. Both of these are 'MatePad' tablets, of course, and PaperMatte Displays ...

Both tablets succeed the MatePad Pro 13.2, a model that has already been compared to the industry-leading iPad Pro. Launched ...

The Senate Judiciary Committee is scheduled to mark up two bipartisan bills Thursday that affordable-drug proponents and generics makers say would make it easier for major pharma companies to game the ...

Akums Drugs and Pharmaceuticals, an India Focused Contract Development and Manufacturing Organizations (CDMO), has been ...

Pimitespib is under clinical development by Otsuka Pharmaceutical and currently in Phase I for Endometrial Cancer.

BR-6002 is under clinical development by Boryung Pharmaceutical and currently in Phase I for Cardiovascular Disease.

The pharmaceutical industry has seen an upswing in 2024 with the Nifty Pharma Index gaining 36 percent year-to-date, compared to 14 percent gains in benchmark Nifty 50. The pharma industry ...

The industry is witnessing consolidation of players, which has led to investment by entities from other sectors. The ongoing consolidation also presents an opportunity to global players to enter the ...

Indian Fintech industry is estimated to be at US$ 150 billion by 2025. India has the 3rd largest FinTech ecosystem globally. * BCG predicts that the proportion of digital payments will grow to 65% by ...